The estimated Net Worth of Joel Sendek is at least $23 Thousand dollars as of 5 July 2018. Joel Sendek owns over 2,000 units of Spero Therapeutics Inc stock worth over $23,023 and over the last 7 years Joel sold SPRO stock worth over $0.
Joel has made over 2 trades of the Spero Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Joel exercised 2,000 units of SPRO stock worth $11,800 on 5 July 2018.
The largest trade Joel's ever made was buying 5,000 units of Spero Therapeutics Inc stock on 6 November 2017 worth over $70,000. On average, Joel trades about 1,750 units every 60 days since 2017. As of 5 July 2018 Joel still owns at least 17,181 units of Spero Therapeutics Inc stock.
You can see the complete history of Joel Sendek stock trades at the bottom of the page.
Joel's mailing address filed with the SEC is C/O SPERO THERAPEUTICS, INC., 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139.
Over the last 15 years, insiders at Spero Therapeutics Inc have traded over $15,920,732 worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth $44,767,755 . The most active insiders traders include Plc Gsk, Jean Francois Formela, and Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of $122,858. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth $7,981.
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
Spero Therapeutics Inc executives and other stock owners filed with the SEC include: